Skip to main content
Saniona logo

Saniona — Investor Relations & Filings

Ticker · SANION ISIN · SE0005794617 LEI · 549300XO4L9XNOCFCZ84 ST Manufacturing
Open in API
Filings indexed 298 across all filing types
Latest filing 2022-02-24 Annual Report
Country SE Sweden
Listing ST SANION

About Saniona

http://saniona.com

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Recent filings

Filing Released Lang Actions
Annual Report 2021
Annual Report Classification · 95% confidence The document is titled 'YEAR-END REPORT FOR SANIONA AB (PUBL) January - December 2021' and contains detailed financial data for the full fiscal year 2021, including revenue, operating loss, net loss, and loss per share. It also includes extensive business highlights, clinical trial updates, strategic priorities, and a letter from the CEO discussing the company's performance and outlook. The length of the document is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content covers comprehensive financial performance and business activities over the entire fiscal year, consistent with an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-02-24 English
Saniona AB’s Nomination Committee for the Annual General Meeting 2022
Regulatory Filings Classification · 95% confidence The document is a press release announcing the composition of the Nomination Committee for the upcoming Annual General Meeting (AGM) 2022. It details the members appointed to the committee and their responsibilities regarding board elections and remuneration proposals. Since this document relates to the preparation and governance structure for an AGM rather than the meeting materials themselves or a specific voting result, it falls under the category of general regulatory announcements or corporate governance-related filings. Given the specific nature of the announcement regarding committee formation, 'RNS' (Regulatory Filings) is the most appropriate classification as it serves as a general corporate announcement.
2021-11-25 English
Saniona AB:s valberedning inför årsstämman 2022
Governance Information Classification · 95% confidence The document is a press release from Saniona AB announcing the composition of its nomination committee (valberedning) ahead of the 2022 Annual General Meeting. It details the members of the committee and the process for shareholders to submit proposals. This type of announcement regarding board-related governance and meeting preparation falls under the category of Governance Information (CGR) as it pertains to the internal rules and board structure preparation.
2021-11-25 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Saniona AB for the period January-September 2021. It contains comprehensive financial statements, including income statements, balance sheet data, and management commentary on business performance, clinical trial progress, and strategic outlook. It is not a mere announcement (RPA) as it provides the full substantive financial data for the specified period. 9M 2021
2021-11-18 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'INTERIM REPORT FOR SANIONA AB (PUBL)' and covers the period 'January - September 2021'. It contains substantive financial data, including revenue, operating loss, net loss, and loss per share for the three and nine months ended September 30, 2021. It also includes detailed management commentary, business highlights, and strategic priorities. It meets the criteria for an Interim/Quarterly Report (IR) as it provides comprehensive financial performance for a period shorter than a full fiscal year. 9M 2021
2021-11-18 English
Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release detailing the resolutions passed at an extraordinary shareholders' meeting, specifically focusing on the election of a new board member and the approval of their remuneration. While it mentions voting results, it is primarily an announcement of the meeting's outcome. Given the specific category for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), this is the most accurate classification as it reports the official results of the shareholder votes.
2021-09-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.